Here's What Analysts Are Forecasting For Springer Nature AG & Co. KGaA (ETR:SPG) After Its Interim Results
It's been a good week for Springer Nature AG & Co. KGaA (ETR:SPG) shareholders, because the company has just released its latest interim results, and the shares gained 7.7% to €19.92. Springer Nature KGaA reported in line with analyst predictions, delivering revenues of €940m and statutory earnings per share of €1.79, suggesting the business is executing well and in line with its plan. This is an important time for investors, as they can track a company's performance in its report, look at what experts are forecasting for next year, and see if there has been any change to expectations for the business. So we gathered the latest post-earnings forecasts to see what estimates suggest is in store for next year.
Taking into account the latest results, Springer Nature KGaA's seven analysts currently expect revenues in 2026 to be €1.98b, approximately in line with the last 12 months. Statutory earnings per share are expected to drop 14% to €1.42 in the same period. Before this earnings report, the analysts had been forecasting revenues of €1.98b and earnings per share (EPS) of €1.37 in 2026. So the consensus seems to have become somewhat more optimistic on Springer Nature KGaA's earnings potential following these results.
Check out our latest analysis for Springer Nature KGaA
There's been no major changes to the consensus price target of €26.14, suggesting that the improved earnings per share outlook is not enough to have a long-term positive impact on the stock's valuation. That's not the only conclusion we can draw from this data however, as some investors also like to consider the spread in estimates when evaluating analyst price targets. Currently, the most bullish analyst values Springer Nature KGaA at €32.40 per share, while the most bearish prices it at €20.00. Analysts definitely have varying views on the business, but the spread of estimates is not wide enough in our view to suggest that extreme outcomes could await Springer Nature KGaA shareholders.
These estimates are interesting, but it can be useful to paint some more broad strokes when seeing how forecasts compare, both to the Springer Nature KGaA's past performance and to peers in the same industry. It's pretty clear that there is an expectation that Springer Nature KGaA's revenue growth will slow down substantially, with revenues to the end of 2026 expected to display 2.8% growth on an annualised basis. This is compared to a historical growth rate of 4.2% over the past year. By way of comparison, the other companies in this industry with analyst coverage are forecast to grow their revenue at 3.6% per year. Factoring in the forecast slowdown in growth, it seems obvious that Springer Nature KGaA is also expected to grow slower than other industry participants.
The Bottom Line
The biggest takeaway for us is the consensus earnings per share upgrade, which suggests a clear improvement in sentiment around Springer Nature KGaA's earnings potential next year. On the plus side, there were no major changes to revenue estimates; although forecasts imply they will perform worse than the wider industry. The consensus price target held steady at €26.14, with the latest estimates not enough to have an impact on their price targets.
With that said, the long-term trajectory of the company's earnings is a lot more important than next year. We have estimates - from multiple Springer Nature KGaA analysts - going out to 2028, and you can see them free on our platform here.
However, before you get too enthused, we've discovered 1 warning sign for Springer Nature KGaA that you should be aware of.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.